Aims-To develop an inmunosorbent agglutination assay for the detection of Toxoplasma gondii IgE antibodies (IgE-ISAGA); to assess its specificity; and to determine the role of specific IgE in the diagnosis of current toxoplasma infection.
The threshold for the IgE-ISAGA was determined using dilution curves. A sample positive for toxoplasma specific IgE was serially diluted in a negative sample. This produced 10 dilutions from 1 in 2 to 1 in 1024 which were then tested in triplicate with the positive and negative samples in both the screening and confirmation tests.
Mean ISAGA matrices from each sample were used to calculate best fit curves, which was performed by computer using Mulicalc (Pharmacia-Wallac, Milton Keynes, UK). The rationale for using a "turning point" (c) is that it is an objective assessment dependent on four characteristics of the curve used to define a sigmoidal plot of the ISAGA matrix reading (y) against the log, value of the sample dilution (x), according to the formula:
where A and D are the upper and lower matrix values (8 or 12 and 0, respectively), B is a slope factor, which depends on the gradient of the middle section of the curve, and M is a symmetry factor for the curve.
Specificity was assessed by measuring toxoplasma specific IgE in 513 samples. The control group comprised 150 serum samples from blood transfusion donations. Fifty serum samples from Paul-Bunnell positive patients and elevated rheumatoid factor patients (mean (SD), 387 (276) units, normal range <30 units) and a further 120 "difficult" serum samples were also tested. The difficult serum samples comprised haemolysed (n = 20), lipaemic (n = 20) and icteric samples (n = 20), samples from pregnant women (n = 20), and samples which had been inactivated for one hour at 60°C (n = 40). The effect of elevated total IgE on specific IgE was examined using 73 serum samples (mean (SD) total IgE 580 (376) ku/l, normal range < 25 ku/l). Interference caused by non-saturation of capture antibody and from abnormal concentrations of other immunoglobulins was determined using 30 serum samples with low total IgE titres (<25 ku/l) and 40 from myeloma patients (13 cases with IgG, 16 with IgA, nine with IgM, and two IgG and IgA myelomas).
A further 108 samples from 65 patients (one to six samples per patient) with recent or current toxoplasma infection were also tested. All of these patients had lymphadenopathy; 33 also had other non-specific symptoms. Biopsies had been performed on 14 in the HIV positive group using the more sensitive Toxo-ISAGA IgM kit (Bio Merieux, Marcy-l'Etoile, France).
Results
Antigen was fixed using 3% formaldehyde in PBS. Lower concentrations of formaldehyde produced an antigen which failed to sediment satisfactorily; higher concentrations reduced sensitivity.
The dilution curves for both the screening and confirmation IgE-ISAGA were sigmoidal (fig 1) . In addition to the best fit curve the computer also calculated its turning point. indicator of recent infection than IgM. 5 6 Although ISAGA appears to be more sensitive than ELISA, ISAGA is subjective as its interpretation depends on the point at which the threshold is set. In the method described here fitting a computer generated curve provided a non-arbitrary way of determining this value. The success of this approach was shown by the very low false positive rate achieved.
Other workers have rarely considered the affect of total IgE on specific IgE. BessieresCathala"2 found that serum samples from patients with toxoplasmosis showed an inconsistent increase in total IgE and specific IgE persisted in latent infections. In this study, however, IgE was measured by a direct ELISA using a primarily cytoplasmic antigen. Specific IgE reactions may have been masked by specific IgG and IgM antibodies5; the inconsistent results may also be explained by the toxoplasma strain, individual patient response, infective dose, or route of infection. 13 Some parasitic infections cause an increase in total IgE concentrations, although in toxoplasmosis this does not appear to be important.14 The latter study, however, was carried out in Brazil in an area where parasitic infection is endemic and the normal range of total IgE was 33-915 IU/ml. Our results were based on normal serum samples with total IgE titres below 50 IU/ml, yet total IgE did not affect specific toxoplasma IgE titres. Although one serum with elevated total IgE concentrations contained specific toxoplasma IgE, other data suggested that this was probably a recent infection.
According to other authors,5 specific IgE is suggestive of infection less than four months previously. These results were from a group of 29 pregnant women, only two of whom had lymphadenopathy. In conclusion, the IgE-ISAGA presented here is easy to use and was found to be both sensitive and specific. Furthermore, it was not affected by abnormal concentrations of total IgE. Among uncomplicated cases of toxoplasmosis, measurement of specific IgE probably has little advantage over detection of specific IgM. However, as specific IgE in most samples is detectable for a shorter period than IgM, it may give a greater indication of current infection. When used in conjunction with other tests, our results suggest that a specific IgE test is useful for the diagnosis of infection during pregnancy and reactivated infections in immunocompromised patients.
